By Gina Shaw
The Trump administration has proposed a new approach to lowering prices for Medicare Part B prescription drugs, by linking them to an International Pricing Index based on sixteen other countries. Specifically targeting expensive biologic drugs, the plan would aim to drop those medications’ prices to levels paid in those index countries over five years.
OCTOBER 27, 2018